InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Ruth Matthew R., Directeur Commercial. Director active across 1 companies, notably Opiant Pharmaceuticals, INC.. In total, 7 reports have been recorded. Total volume traded: €59k. The latest transaction was disclosed on 27 June 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations7 total
02,000 shares0
Common Stock
SEC:0001385508-22-000099:0·
012,000 shares0
Common Stock
SEC:0001385508-22-000009·
012,000 shares0
Common Stock
SEC:0001385508-22-000009:0·
€29,3642,000 shares@ €14.6821100.0% of flow
Common Stock
SEC:0001385508-21-000121·
Ideal exit: 28 May 2022 (T+270)
€29,3642,000 shares@ €14.682150.0% of flow
Common Stock
SEC:0001385508-21-000121:0·
Ideal exit: 28 May 2022 (T+270)
015,000 shares0
Common Stock
SEC:0001385508-21-000096·
015,000 shares0
Common Stock
SEC:0001385508-21-000096:0·
7 of 7 declarations
About Ruth Matthew R.
Matthew R. Ruth is the Chief Commercial Officer at OPIANT PHARMACEUTICALS, INC. In this role, he is responsible for the company's commercial strategy and business development. His expertise in the pharmaceutical sector is essential to support OPIANT's growth. Matthew R. Ruth collaborates with his team to develop initiatives that promote product innovation and expansion.
